Normal view MARC view ISBD view

Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

By:

Material type: Text

TextSubject(s):

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	URL	Status	Date due	Barcode
eBooks			Link to resource	Available

There are no comments on this title.

to post a comment.